...
首页> 外文期刊>Molecular pharmacology. >The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-D-Aspartate Receptors
【24h】

The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca2+ Permeability of GluN1/GluN2A N-Methyl-D-Aspartate Receptors

机译:负变性调节剂Eu1794-4可降低Glun1 / glun2a n-甲基-d-天冬氨酸受体的单通道电导和Ca2 +渗透性

获取原文
获取原文并翻译 | 示例
           

摘要

NMDA receptors are ligand-gated ion channels that mediate a slow, Ca2+-permeable component of excitatory synaptic currents. These receptors are involved in several important brain functions, including learning and memory, and have also been implicated in neuropathological conditions and acute central nervous system injury, which has driven therapeutic interest in their modulation. The EU1794 series of positive and negative allosteric modulators of NMDA receptors has structural determinants of action near the preM1 helix that is involved in channel gating. Here, we describe the effects of the negative allosteric modulator EU1794-4 on GluN1/GluN2A channels studied in excised outside-out patches. Coapplication of EU1794- 4 with a maximally effective concentration of glutamate and glycine increases the fraction of time the channel is open by nearly 1.5-fold, yet reduces single-channel conductance by increasing access of the channel to several subconductance levels, which has the net overall effect of reducing the macroscopic current. The lack of voltage-dependence of negative modulation suggests this is unrelated to a channel block mechanism. As seen with other NMDA receptor modulators that reduce channel conductance, EU1794-4 also reduces the Ca2+ permeability relative to monovalent cations of GluN1/GluN2A receptors. We conclude that EU1794-4 is a prototype for a new class of NMDA receptor negative allosteric modulators that reduce both the overall current that flows after receptor activation and the flux of Ca2+ ion relative to monovalent cations.
机译:None

著录项

  • 来源
    《Molecular pharmacology.》 |2021年第5期|共13页
  • 作者单位

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Dept Chem 1515 Pierce Dr Atlanta GA 30322 USA;

    Emory Univ Dept Chem 1515 Pierce Dr Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

    Emory Univ Dept Chem 1515 Pierce Dr Atlanta GA 30322 USA;

    Emory Univ Sch Med Dept Pharmacol &

    Chem Biol Atlanta GA 30322 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号